Health, Fitness & Food

Dr. Anthony Fauci, White House Chief Medical Advisor and Director of the NIAID, responds to questions from Sen. Rand Paul (R-KY) at a Senate Health, Education, Labor, and Pensions Committee hearing on Capitol Hill on January 11, 2022 in Washington, D.C. Greg Nash | Pool | Getty Images White House chief medical advisor Dr. Anthony

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT A health worker administers a dose of Pfizer covid-19 vaccine to a man at the Sanford Civic Center. With the emergence of the Omicron covid-19 variant in numerous countries, including the United States, the US Centers for Disease Control (CDC) encouraged all vaccinated adults to

Estee Lauder (EL) and other Club holdings with meaningful exposure to the Chinese economy bounced Friday, following news that BioNTech ‘s (BNTX) Covid vaccine will soon be available to foreign residents living in China. We’re cautiously optimistic about the vaccine development , which adds to hopes that Beijing will soften its restrictive pandemic policies after

A nurse administers a flu vaccination shot to a woman at a free clinic held at a local library on October 14, 2020 in Lakewood, California. Mario Tama | Getty Images The U.S. is facing the highest flu hospitalization rates in more than a decade with children and the elderly most at risk, according to

Four of our Club holdings — Costco Wholesale (COST), Amazon (AMZN), Humana (HUM) and Bausch Health (BHC) — were in the news Thursday. Here’s how we feel about the developments. Costco The news: Costco reported sales for the retail month of October after the closing bell Wednesday evening. In the four-week period, net sales increased 7.7%

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. It’s not too late to sell Quick mentions: QCOM, COST, HUM 1. It’s not too late to sell Stocks fell on Thursday, continuing Wednesday’s losses after the Federal Reserve reaffirmed

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Fed decision ahead Quick takes on Club earnings 1. Fed decision ahead Stocks edged down Wednesday ahead of the Federal Reserve’s decision on interest rate increases, set for this afternoon.

Club holding Humana (HUM) reported a mixed-but-solid third quarter before the opening bell Wednesday. Early optimism about 2023 also supported our bullish view on the health insurer’s stock. Revenue increased 9% year-over-year to $22.75 billion, slightly below estimates of $22.76 billion, and adjusted earnings-per-share increased 42% to $6.88, exceeding estimates of $6.28 per share. Aiding

Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report issued earlier in the day . “The underlying fundamentals of the business are really strong,” Ricks said in a CNBC interview with Jim Cramer. “Seventy percent of our

Johnson & Johnson ‘s (JNJ) $16.6 billion deal to buy heart pump maker Abiomed (ABMD) will bolster its pharmaceutical and medical device business ahead of J & J’s plans to separate its consumer division into a separate company. The Abiomed acquisition is set to close at the end of the first quarter of 2023. The

A woman receives a dose of a vaccine against the coronavirus disease (COVID-19) at a sport stadium during the coronavirus disease pandemic, in Vina del Mar, Chile, April 22, 2021. Rodrigo Garrido | Reuters Long Covid is more common among women than men, according to federal data. More than 17% of women have had long

Club holding Humana (HUM) got an upgrade on Wall Street on Wednesday, exactly one week before the health insurer reports earnings. Deutsche Bank took Humana to a buy rating from a hold, citing its “leading position in Medicare Advantage,” a key reason we own the company as a defensive play in this tough economic environment.

The new COVID-19 booster which includes protection for Omicron at AltaMed Health Services in South Gate on Thursday, October 6, 2022. Sarah Reingewirtz | MediaNews Group | Los Angeles Daily News via Getty Images Two studies are raising doubts about whether the new omicron BA.5 booster really will offer better protection against Covid than the

We’re exiting our position in AbbVie (ABBV), selling 300 shares at roughly $148.14 each. We’re also buying 75 shares of Starbucks (SBUX) at roughly $85.93 each. Following Friday’s trades, Jim’s Charitable Trust will no longer own a position in AbbVie and will own 750 shares of Starbucks, increasing its weighting in the portfolio to 2.28%

A pharmacist prepares to administer COVID-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 09, 2022 in Chicago, Illinois. The recently authorized booster vaccine protects against the original SARS-CoV-2 virus and the more recent omicron variants, BA.4 and BA.5. Scott Olson |

A rendering of COVID-19 new Omicron sub-variant BQ.1.1 Koto_feja | E+ | Getty Images Two omicron subvariants that are resistant to key antibody treatments are on the rise in the U.S., according to data from the Centers for Disease Control and Prevention. The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S.,

AbbVie (ABBV) reported a mixed second-quarter Friday morning. Despite a pullback in shares after the release, we decided to lock-in a great 61% return and exit a stock that has been one of this year’s winners. We never like to sell on a down day, but multiple quarters in a row of revenue misses raised our

Covid cases and controls have increased in China this month. Pictured here on Oct. 27, 2022, is a neighborhood in Shanghai that’s been fenced in for Covid control. Future Publishing | Future Publishing | Getty Images BEIJING — Covid controls in China have tightened in the last two weeks after more cities reported virus outbreaks.

Medical staff treat a coronavirus disease (COVID-19) patient on the Intensive Care Unit (ICU) at the Cleveland Clinic in Cleveland, Ohio, January 7, 2022. Shannon Stapleton | Reuters Emerging omicron subvariants are resistant to key antibody treatments for HIV patients, kidney transplant recipients and other immunocompromised people, making them particularly vulnerable to Covid this winter,

Founder and CEO of Maven Clinic Kate Ryder, the first female health tech unicorn, valued at $1 billion. Daniel Zuchnik | Getty Images Entertainment | Getty Images Women account for half of consumers, hold power over 80% of household financial decisions and make 70% of health-care-related decisions in their families – but their access to